Skip to content

Effect of Sulfur Thermal Water on Circulating H2S Levels and Markers of Bone Metabolism in Osteopenic Subjects.

Effect of Sulfur Thermal Water on Circulating H2S Levels and Markers of Bone Metabolism in Osteopenic Subjects.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06095349
Acronym
FORST3
Enrollment
50
Registered
2023-10-23
Start date
2019-10-01
Completion date
2023-11-30
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrogen Sulfide, Osteoporosis

Brief summary

The aim of the study is to investigate whether inhalation treatment with high-sulfide waters from some spas (referred to as thermal waters), performed for 12 consecutive days, is able to change circulating H2S levels and alter bone metabolism. Identifying a clear correlation between circulating levels of H2S and sulfur water administration, as well as a potential anabolic effect on bone, would set the stage for new studies that could have important clinical implications for promoting health and preventing osteoporosis

Interventions

OTHERinhalatory treatment with sulfureous aerosol

osteopenic patients are subject to a 12-days cycle of 30 minutes-long inhalatory treatment with sulfureous aerosol

Sponsors

Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* post-menopausal women with a diagnosis of osteopenia

Exclusion criteria

* concurrent muscoloskeletal conditions or chronic pharmacological treatment interfering with bone metabolism

Design outcomes

Primary

MeasureTime frameDescription
Measurement of biomarkers of bone turnover, marker #315 daysserum C-terminal telopeptide of type I collagen (CTX-1), marker of bone resorption
Measurement of biomarkers of bone turnover, marker #115 daysProcollagen type 1 N-terminal propeptide (P1NP), marker of bone formation
Measurement of biomarkers of bone turnover, marker #215 daysBone-specific alkaline phosphatase (BAP), marker of bone formation

Secondary

MeasureTime frameDescription
Measurement of serum H2S levels15 daysserum H2S levels will be assessed through HPLC

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026